The introduction of advanced laparoscopic operations in the early 1990s led to a close examination of the immunologic consequences of both open and closed surgical methods. This scrutiny has significantly increased our understanding of the impact of surgery on the body and will, it is hoped, lead to new perioperative pharmacologic therapies that will lessen the deleterious immunologic effects of all types of surgery. Before the laparoscopic era, it had been well established that major open surgery is associated with the temporary suppression of a variety of cells that are involved with both innate and specific immunity, including lymphocytes, neutrophils, monocytes, and macrophages. Interactions between cells, chemotaxis, expression of surface antigens, the ability to produce cytokines, and other functions of these immune system cells are negatively influenced by open surgical trauma. Further, the ability to mount a positive response to a delayed-type hypersensitivity (DTH) recall antigen challenge is suppressed after surgery [1][2][3][4][5].
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The relative contribution of each part of an abdominal procedure (abdominal wall access incision versus intraabdominal dissection and resection) to postsurgical immunosuppression had not been assessed before the advent of advanced laparoscopic methods. The results of recent studies suggest that the method of entry into the abdomen is the most important determinant of postoperative immune function. Minimally invasive methods, for a variety of immune parameters, have been shown to be associated with significantly better preserved function when compared to the equivalent open procedure. Of note, in many cases the differences are small and short lived, on the order of a day, and sometimes less for several variables. For a number of parameters no differences have been noted.
It should be realized that the clinical significance, if any exists, of the immune function differences that have been found has not been determined. Better preserved postoperative cell-mediated immune function, in theory, may have an impact on the rate of infections and, possibly, tumor recurrence rates and survival.
This chapter reviews the available literature in this area and also speculates on how our improved understanding of surgery's impact on the immune system may lead to novel perioperative treatments in the future.
A. Delayed-Type Hypersensitivity
One of the simplest methods of evaluating immune function is via delayedtype hypersensitivity (DTH) testing. The ability to mount a DTH response to an intradermally injected antigen to which the subject has been previously exposed verifies that several important elements of the immune system are functioning. A positive response, as indicated by the development of an indurated area at the site of injection, requires (1) that the antigen be processed and presented to a specific CD4+ T lymphocyte by an antigen-presenting cell (APC), (2) activation and replication of the CD4+ T lymphocyte and cytokine elaboration, and (3) accumulation of "effector" cells as well as deposition of fibrin at the challenge site. In the perioperative setting, serial DTH challenges, done both before and after surgery, provide the observer with some idea of the functional status of the immune system at different time points and permit comparison of postoperative responses to the patient's baseline preoperative response. Although a diminished DTH reaction is believed to correlate with a decrease in the functional status of the cell-mediated immune system, thus far it has not been demonstrated that patients with significantly decreased postoperative DTH responses have an increased rate of complications.
In mice, it has been shown that both sham laparotomy and open bowel resection via a full laparotomy are associated with a significant decrease in the size of the DTH responses for at least 5 days after surgery. The equivalent laparoscopic procedures, in contrast, were associated with significantly better preserved DTH responses [7, 8] . Two human DTH studies have been done, a cholecystectomy and a colectomy study; both were fairly small and nonrandomized. Both studies demonstrated that the open procedure was associated with a significant drop in the size of the response whereas the minimally invasive groups had smaller nonsignificant decreases [9, 10] . These studies, and others, suggest that early after surgery cell-mediated immune function is better preserved after laparoscopic procedures.
B. Lymphocyte Proliferation
Inherent to cellular immunity is lymphocyte function, which can be assessed in a number of ways. One method is to perform lymphocyte proliferation assays (LPA). In an LPA, lymphocytes from peripheral blood samples are exposed, in vitro, to a mitogen such as lipopolysaccharide, and their degree of proliferation measured. A decreased proliferation rate suggests that cellular immune function 
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